Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Nomination Summary for Local anesthetics & metabolites (N20041)

Nominated Substances: Bupivacaine, Bupivacaine hydrochloride, Etidocaine, Mepivicaine, Mepivicaine hydrochloride, Prilocaine, Prilocaine hydrochloride, Ropivacaine

Nomination Date: 09/00/2000

Nominator: NIEHS

Rationale: Local anesthetics have widespread clinical use and human exposure including prenatal/postnatal exposure. Some of these compounds may be metabolized to carcinogenic and neurotoxic intermediates. NIEHS has identified for nomination local anesthetics that contain the 2,6-xylidine or o-toludine substructure for metabolism and mutagenicity studies.

NTP Principles: 1, 2, 3, 7

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 38396-39-3

Agent Name: Bupivacaine

CASRN: 14252-80-3

Agent Name: Bupivacaine hydrochloride

CASRN: 1722-62-9

Agent Name: Mepivicaine hydrochloride

CASRN: 721-50-6

Agent Name: Prilocaine

CASRN: 1786-81-8

Agent Name: Prilocaine hydrochloride